Physician profile
John B Dalton
NPI 1629041231
$1,736.71
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $415 · 2020: $504 · 2021: $431 · 2022: $386.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $390.94 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $285.27 | 2019-2022 | |
| Glaxosmithkline, LLC. | $267.53 | 2020-2022 | |
| Amarin Pharma, INC. | $125.16 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $101.23 | 2019-2020 | |
| Pfizer INC. | $95.18 | 2019-2022 | |
| Abbott Laboratories | $87.39 | 2020-2021 | |
| Abbvie INC. | $86.13 | 2021-2022 | |
| Lilly USA, LLC | $51.52 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $50.99 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $44.57 | 2019-2022 | |
| Sanofi Pasteur INC. | $24.28 | 2019-2020 | |
| Biohaven Pharmaceuticals, INC. | $20.39 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $14.93 | 2022 | |
| Novartis Pharmaceuticals Corporation | $14.44 | 2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $13.86 | 2022 | |
| Horizon Therapeutics Plc | $13.03 | 2022 | |
| Xeris Pharmaceuticals, INC. | $12.78 | 2022 | |
| Ironwood Pharmaceuticals, INC | $12.77 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $12.59 | 2022 | |
| Allergan, INC. | $11.73 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Dalton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.